AA
SCLN

Ancora Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Ancora Advisors’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-60,000
Closed -$672K – 710
2017
Q3 		$672K Hold
60,000
– – 0.04% 399
2017
Q2 		$660K Buy
+60,000
New +$600K 0.04% 379

Ancora Advisors's SCLN Position: Q4 2017 in Review

Ancora Advisors sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 60,000 shares — an estimated $672K sold.

Ancora Advisors first reported a position in SCLN in Q2 2017 and held it in 2 quarters. The position peaked at $672K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Ancora Advisors reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Ancora Advisors sold 60,000 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $672K.
  • Ancora Advisors first reported a position in Sciclone Pharmaceuticals Inc in Q2 2017 and held it in 2 quarters.
  • Ancora Advisors's Sciclone Pharmaceuticals Inc position peaked at $672K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Ancora Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.